Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | 5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | HCID 17750399 | — |
| Reactant | HCID 66701057 | HCID 66701057 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 59483855 | HCID 59483855 | — |
Reaction Steps
1,1′-Carbonyldiimidazole (119 mg, 0.741 mmol) and 5-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid (200 mg, 0.706 mmol) were dissolved in dichloromethane (5 ml) and N,N-dimethylformamide (3 ml) and stirred for 1 h at room temperature. 3-(Pyridin-4-yl)-3,9-diazaspiro[5.5]undecane dihydrochloride (322 mg, 1.059 mmol), dissolved in a mixture of dichloromethane (5 ml) and triethylamine (0.293 ml, 2.118 mmol), was then added dropwise and the reaction mixture was stirred for 3 days at room temperature. The mixture was diluted with dichloromethane (50 ml) and washed with saturated sodium hydrogen carbonate solution (3×10 ml) and with saturated sodium chloride solution (10 ml), dried over sodium sulfate and concentrated in vacuo. The crude product was purified by column chromatography (silica gel, ethyl acetate/methanol, 5:1). Yield: 280 mg (80%)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08357717B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-5ccbbdd9e4ae49e3b1d9a92a745083ed |
|---|
| Source note | uspto-grants-2013_01 |
|---|